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Severe dental caries as the first presenting clinical  
feature in primary Sjögren’s syndrome 
 
 
Abstract 
Background: Sjögren’s syndrome is an autoimmune syndrome involving the exocrine 
glands specially the salivary and lacrimal glands leading to xerostomia and xerophtalmia. 
This paper presents a case with primary Sjögren’s syndrome that severe dental caries were 
the first clinical manifestation.  
Case Presentation: A 42-year-old man was referred to the School of Dentistry, Tehran 
University of Medical Sciences due to unexplained severe dental decays. After systematic 
evaluation and consultation with the rheumatologist and the ophthalmologist, the diagnosis 
of primary Sjögren’s syndrome was suggested and confirmed by serologic and 
histopathologic study. 
Conclusion: Primary Sjögren’s syndrome should be considered in the differential 
diagnosis of patients with early severe dental caries.  
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Sjögren’s syndrome (SS) is a chronic systemic autoimmune disease by slow 
progression that affects principally the salivary and lacrimal glands leading to xerostomia 
and xerophtalmia. The involvement of the exocrine glands of the skin, pancreas, and 
vagina, respiratory and gastrointestinal systems has also been described. Extraglandular 
manifestations such as musculoskeletal, skin, renal, hematologic, neurologic, 
gastrointestinal and pulmonary involvement may coexist in some patients (1-4). 
Histopathological hallmark of the disease is persistent with progressive focal mononuclear 
cells infiltration, predominantly lymphocytes (2, 5). Primary SS patients have an enhanced 
risk of malignant lymphoma (non-Hodgkin’s lymphoma), compared with the normal 
population (5). The etiopathogenesis of this syndrome is multifactorial and suggested 
infectious agents (Epstein- Barr virus, cytomegalovirus, parvovirus and retrovirus), 
immunologic changes in glandular homeostasis, humeral imbalance (6-12).  
The extension of the pathological process beyond the lacrimal, salivary and other 
exocrine glands into peri-epithelial and extra-epithelial tissues can cause systemic 
manifestations that involve the lungs, kidneys and others. The appearance of the disease 
alone is called primary Sjögren’s syndrome and the accompaniment with the other 
rheumatic diseases is named secondary Sjögren’s syndrome (3). This case report explained 
a middle-aged man with the history of severe and unusual dental decays as the first 
troublesome feature of SS.  
 
Case presentation 
A 42-year-old man with multiple dental caries that compromised his esthetic 
appearance was referred to the postgraduate operative department of Tehran School of 
Dentistry in May 2011. His chief complaint (earliest symptom) was severe dental caries 
approximately 8 years ago.  
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Difficulty in swallowing dry food, continuous speaking, 
foreign body sensation and redness in eyes were the other 
problems which started about 2 years ago. Past medical 
history was unremarkable, besides consumption of 
nortriptyline 2 years ago for 1 year duration and also 
repeated restorative treatments for several carious teeth were 
done 8 years ago which eventually failed. The clinical oral 
exam by the dentist illustrated multiple dental caries (figure 
1). No swelling and abnormalities were observed in the head 
and neck except red eyes and cracking of lips and oral 
corners. There was not any redness or thinning of oral 
mucosa. The primary treatment for dental health was the 
removal of acute caries and performing caries control 
process.  The use of fluoride mouth wash, avoidance of 
cariogenic diet, chewing xylitol gum and good oral hygiene 
were recommended to him.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Severe dental decays in facial and cervical 
aspect of anterior mandibular teeth and cervical aspect 
of anterior maxillary teeth 
 
Regarding the ophthalmic and oral manifestations and 
severe unusual dental caries even with good oral hygiene, 
systemic disease was suspected as the cause of the patient’s 
problems. Therefore, consultation with rheumatologist and 
also ophthalmologist was performed. Systematic evaluation 
by rheumatologist revealed a history of intermittent 
arthralgia and also morning stiffness in peripheral joints 
without swelling. Ocular examination by the ophtalmologist 
showed conjunctivitis and mucosal threads and photophobia. 
With the request of the rheumatologist, Schirmer’s test was 
done by ophthalmologist for measuring ocular tear. The 
result of the test established ocular dryness. So, the ocular 
manifestations were attributed to keratoconjunctivitis sicca. 
Considering the obtained findings include difficulty in 
swallowing dry foods, severe dental caries, 
keratoconjunctivitis, subjective and objective manifestations 
of ocular dryness and also arthralgia, diagnosis of Sjögren’s 
syndrome was suggested by rheumatologist. Blood 
chemistry tests, complete blood count and urinalysis were 
within the normal range, except mild lymphopenia (white 
blood cells: 4640/ mm
3
, lymph: 1380/ mm
3
). C-reactive 
protein (CRP) titer and ESR in first hour were normal. 
Abnormal immune serum tests included anti-RO (SSA): 178 
RU/ml (normal: up to 20), RF titer: more than 150 IU/ml 
(normal: up to 15) and FANA: 1/1280 (normal: up to 1/80, 
pattern: fine speckled). The results of anti-LA (SSB), anti 
CCP, anti dsDNA and HIV (PCR) were negative.  
The obtained biopsy from lip by otolaryngologist 
confirmed chronic sialadenitis in minor salivary glands. 
Histopathology assessment by the oral pathologist and also 
the physician pathologist clarified infiltration of lymphocytes 
compatible with Sjögren’s syndrome (foci score: 2) (figure 
2). Treatment was designed to relive symptoms. Artificial 
tear and Liposic eye gel (as a lubricant) were prescribed by 
ophthalmologist for ocular symptoms. For arthralgia and 
morning stiffness, hydroxychloroquine (HCQ) 400 mg/day 
and prednisolone 5 mg/day were prescribed by the 
rheumatologist. For oral symptoms, the use of artificial 
saliva and fluoride mouthwash, drinking plentiful water and 
watery foods, chewing xylitol gum and good oral hygiene 
were recommended by the dentist and definitive resin 
composite restorations were performed. A dental health 
follow-up plan was also designed for him. A follow up of the 
patient after two months revealed moderate improvement of 
clinical manifestations. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Histopathology study revealed at least two foci 
of lymphocytes, a cluster of at least 50 lymphocytes in 4 
mm
2, in minor salivary glands of patient’s lip (focus 
score: 2) 
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Discussion 
We presented a case of primary Sjögren’s syndrome with 
early severe dental caries in which his disease was diagnosed 
with several years delay. Xerostomia is the main symptom of 
SS but some patients (like our case) may not complain about 
it. The other symptoms that often occur along with 
xerostomia include frequent thirst, burning sensation on the 
tongue, red and raw tongue, difficulty swallowing, taste 
problems, sore throat, hoarseness, problems with speech, dry 
and cracked lips, dental problems increment such as cavities 
and periodontal disease (1, 6). Our case had difficulty 
swallowing, dry and cracked lips, problems in continuous 
speech and severe early dental caries.  
Common therapeutic management is based on controlling 
sicca features using topical and cholinergic agents. 
Extraglandular features are controlled with glucocorticoids 
and immunosuppressive drugs. Anti-tumor necrosis factor 
agents have not shown clinical efficacy. No significant 
improvement in sicca outcomes were seen for oral 
prednisone or hydroxychloroquine (13). But in an open 
study, hydroxychloroquine which increases the PH of 
endosomes and thus, decreases type 1 IFN secretion has been 
found effective for the treatment of decreasing saliva (14). 
Therefore, we used it for sicca features in our case, as well.  
Concerning the history, characteristic features and 
diagnostic approach of the presented case may guide 
clinicians through some viewpoints and views in order to 
diagnose SS in early stages.  
1) Some oral manifestations may occur before the 
progression of symptomatic xerostomia. The lack of 
knowledge about these features (such as severe dental caries) 
may lead to the underestimation or the later diagnosis of SS. 
In fact, changes in saliva biochemistry before the decrease of 
saliva, changes in pH and buffer capacity of saliva and also 
reduction in re-mineralization activity and antimicrobial 
properties of saliva may lead to early dental loss and 
unexplained early dental decays as showed by others (1, 3).  
2) The dentist or physician should be suspicious to 
Sjögren’s syndrome when severe and early dental caries 
(onset before 40 years old, especially in cervical aspect of 
teeth) or hypo-salivation accompanied with other co- 
morbidities pertaining to this syndrome without history of 
xerostomia-inducing drugs, poor oral hygiene condition or 
incorrect dietary regimen and also when multiple dental 
decays reoccur in a short period of time even after repeated 
restorations.  
3) Interdisciplinary approach for diagnostic and 
therapeutic management with cooperation of dentist, 
rheumatologist, ophthalmologist, otolaryngologist and 
pathologist, who will otherwise focus only on those 
symptoms that encompass their areas of expertise, can get a 
comprehensive image of the patient, leading to the earlier 
diagnosis and treatment of SS before irreversible destructive 
changes in salivary glands and other glandular or 
extraglandular complications. 
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